Search Results
Synthego Overview
The Synthego Advantage for CRISPR Outsourcing
Enabling GMP Production of sgRNA for CRISPR-Based Cell and Gene Therapies
Forge a Successful CRISPR Therapeutic Path with High-Quality GMP sgRNA
Synthego Is Working To Make Gene Editing As Easy As Coding | CNBC
Synthego's Continuum
Synthego
Design, Edit, Analyze and Maximize Your CRISPR-Cas9 Editing Efficiency
Synthego Continuum Overview
How Multi-guide sgRNA Delivers Reliable Knockouts
Founder Stories: Paul Dabrowski - Co-Founder and CEO of Synthego, automating gene editing
Synthego